Has Paul Murray, MD received payments from drug or device companies?

Yes. Drug and device makers reported $64,384 in general payments to Paul Murray, MD across 28 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Murray, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Murray, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Murray, MD

Adult Reconstructive Orthopaedic Surgery · Hartford, CTNPI 1376518035

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $60,413 of the $64,384 with a category attached, or 93.8%. Stryker accounts for 99.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $48,063 and has fallen 98.3% since, to $818 in 2022.

$64,384in general payments, 2019–2025

Across 28 payments — averaging $2299.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$64K
Smith+Nephew$139
Kowa Pharmaceuticals America, Inc.$15

What the payments were for

Consulting fees$60,41394%
Travel & lodging$3,0975%
Food & beverage$8741%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	26	$64,230
Smith+Nephew	1	$139
Kowa Pharmaceuticals America, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Connecticutto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$225,499

Medicare patients

451

Services billed

4,330

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Amoxicillin	29	$24

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Hartford

Donald AllenHartford$7K
Jeffrey BurnsHartford$4K
Mark ShekhmanHartford$1K
Jenna BernsteinTrumbull$273K
Christopher LynchBranford$48K
Thomas HickernellStamford$45K
Arthur ManoliWilton$25K
Elie MansourNew Haven$24K
Ryan CharetteWallingford$16K
Derek ShiaHamden$7K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →